Inhibitors of plasma kallikrein
US10221161B2 · kind B2 · utility
13Cited by
1References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 2014 |
| Grant date | Mar 5, 2019 |
| Priority date | — |
| Expiry date | Aug 14, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (I), compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R5, R6, R7, R12, R13, A, L, B, n, W, X, Y and Z are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.